Insmed (INSM) announced a collaboration with Google (GOOG) Cloud to transform the drug discovery, development, and commercialization landscape of the life sciences industry through the use of generative AI. This alliance will harness the power of Google Cloud’s AI technology and Insmed’s expertise in serious and rare diseases with a goal of reducing the time and increasing the efficiency of developing and delivering new medicines to appropriate patients. The collaboration focuses on four key aspects of the life sciences industry-drug discovery, drug development, drug commercialization, and enabling functions-and has already identified one to three projects under each area for completion within the next 18 months, with multiple additional programs to follow. Insmed has built a generative AI search capability using Vertex AI Search trained on its internal documentation, as well as separate functionality that enables indexed access to available, external medical publications.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on INSM:
- Insmed (INSM) Q3 Earnings Cheat Sheet
- 5 Mid-Cap Stocks with Analyst Approval – October 2023
- Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call
- Insmed reports inducement grants under NASDAQ listing rule
- Biotech Alert: Searches spiking for these stocks today
Questions or Comments about the article? Write to editor@tipranks.com